David Alberts

Research Interests

David S. Alberts, M.D., is the Director of the University of Arizona Cancer Center, as well as a Regents Professor of Medicine, Pharmacology, Public Health at the Nutritional Sciences & BIO5 Institute. After training in hematology and oncology at the National Cancer Institute, Alberts ultimately moved to the University of Arizona Cancer Center, where he served as Director of the Pharmacology Program from 1978 to 1989 and the Cancer Prevention and Control Program from 1989 to 2005.

Dr. Alberts has been funded by the National Cancer Institute yearly since 1971 for laboratory and clinical research related to the clinical pharmacology of cancer chemotherapy and chemopreventive agents. In June 2001, he was rated by Science as the third highest funded clinical research scientist by the NIH. He has published more than 550 peer-reviewed manuscripts, 100 book chapters, 60 invited articles and has 8 edited books.

Between 1982 and 1984, Dr. Alberts served as the Chair of the Oncologic Advisory Committee to the U.S. Food and Drug Administration. He is the recipient of the Joseph Burchenal Clinical Research Award (2003) and Cancer Prevention Award (2004) from the American Association for Cancer Research (AACR), the Distinguished Career Award for Cancer Prevention from the American Society of Preventive Oncology (2004) and the second annual Pioneer in Cancer Prevention Award from the AACR (2014). Currently, Dr. Alberts serves as the Contact Principal Investigator or Co-PI on more than $25 million of National Cancer Institute funding.